COMPARISON OF HISTOPATHOLOGICAL FEATURES BETWEEN PRIMARY AND RECURRENT ORAL SQUAMOUS CELL CARCINOMAS: IMPLICATIONS FOR MANAGEMENT STRATEGIES
DOI:
https://doi.org/10.33279/jkcd.v14i03.722Keywords:
Oral squamous cell carcinoma, primary tumors, recurrent tumors, histopathological featuresAbstract
Objectives: To assess clinical and histopathological characteristics of primary and recurrent OSCC about the tumor site, grade, stage, lymph node involvement, and tobacco habits, which determine the prognosis and recurrence.
Materials and Methods: Our cross-sectional study recruited 80 consecutive participants i-e 40 patients with primary tumors and 40 patients with secondary/recurrent tumors. The study was conducted in Bacha Khan College of Dentistry in a time of 5 years. The participants were divided into two groups i-e primary tumors (without recurrence) (n=40) and secondary tumors (with recurrence) (n=40). The participant’s age, gender, history of tobacco use, tumor location, management, grade, stage, presence or absence of recurrence, and survival rates were collected from the clinical records and tumor registers. OSCC slides (both primary and recurrent) were collected from the department of pathology Bacha Khan College of Dentistry to confirm the diagnosis of the primary and secondary tumors. The recurrent tumor sites were identifi ed as local, secondary, or distant sites. The recurrence of the tumor was confirmed histologically and was considered in patients with advancement of the disease and had no cure to treatment. The second primary tumors within the site were also considered recurrent tumors. Tumor grading was performed according to the WHO classifications and survival analysis was performed using the Kaplan-Meier and Cox proportional hazards regression to determine effects of these features on overall survival and cancer-specific survival. Results: The Kaplan-Meier estimator test established differences in survival characteristics of primary and recurrent tumors, with tobacco use significantly present. In this study, a history of tobacco use was associated with a poorer overall survival of patients (p=0.04), as well as cancer-specific survival (p=0.04). However, clinically, tobacco use has been shown not only to be an independent risk factor for OSCC but also a signifi cant factor for tumor recurrence and poor survival, which demands an effective control in smokers. We also noted that primary tumor site inflenced survival: patients with tumor in the buccal mucosa had worst survival rates (p = 0.04). Furthermore, lymphatic infiltration was identified as an independent predictor of poor prognosis and hazardous for both OS and cancer-related survival (p = 0.006). These imply the need for closer follow-up and assertive intervention on patients who exhibit lymphatic spread and particular anatomic site manifestation.
Conclusion: Continued tobacco use, buccal mucosa tumors, and patients with lymphatic infiltration were found to have poor survival rates which indicated that such patients require more intense treatment modalities. These results underscore the need for the inclusion of the factors in the management of care especially on smoking cessation, targeted therapies, and frequent follow-up of patients with unfavorable molecular profiles. However, due to its single-institution design and low number of cases included, the generalization of our findings is restrained; therefore, more extensive investigations should be conducted in the future to validate and further develop our
findings in OSCC prognosis.
References
Kumar SA, Indu S, Gautami D, VarRuchi S. Oral squamous cell carcinoma (OSCC) in humans: Etiological Factors, diagnostic and therapeutic relevance. Research Journal of Biotechnology Vol. 2020;15:10.
Givony S. Oral squamous cell carcinoma (OSCC) an overview. J Med Sci. 2020;8:67-74.
Meram AT, Woo BM. Oral Cancer Management. Peterson’s Principles of Oral and Maxillofacial Surgery. 2022:1009-55.
Liu Y, Yang M, Luo J, Zhou H. Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer. International journal of oral science. 2020;12(1):19.
Zittel S, Moratin J, Horn D, Metzger K, Ristow O, Engel M, et al. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study. Clinical Oral Investigations. 2022:1-10.
Verma P, Kaur P, Al Asmari DS. Squamous cell carcinoma of mandible with unusual clinical presentation: a rare case report and review of literature. Indian Journal of Dental Research. 2021;32(2):256-60.
Su Y-F, Chen Y-J, Tsai F-T, Li W-C, Hsu M-L, Wang D-H, et al. Current insights into oral cancer diagnostics. Diagnostics. 2021;11(7):1287.
Weckx A, Riekert M, Grandoch A, Schick V, Zoeller JE, Kreppel M. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral oncology. 2019;94:8-13.
Caldeira PC, Soto AML, de Aguiar MCF, Martins CC. Tumor depth of invasion and prognosis of early‐stage oral squamous cell carcinoma: A meta‐analysis. Oral diseases. 2020;26(7):1357-65.
Silva GVD, da Silva Dolens E, Paranaíba LMR, Ayroza ALC, Gurgel Rocha CA, Almangush A, et al. Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis. Journal of Oral Pathology & Medicine. 2023;52(5):402-9.
Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral oncology. 2021;121:105451.
Mroueh R, Nevala A, Haapaniemi A, Pitkäniemi J, Salo T, Mäkitie AA. Risk of second primary cancer in oral squamous cell carcinoma. Head & Neck. 2020;42(8):1848-58.
Malhab LJB, Saber-Ayad MM, Al-Hakm R, Nair VA, Paliogiannis P, Pintus G, et al. Chronic inflammation and cancer: The role of endothelial dysfunction and vascular infl ammation. Current Pharmaceutical Design. 2021;27(18):2156-69.
Marinelli LM, Chatzopoulos K, Marinelli JP, Chen TY, Collins AR, Sotiriou S, et al. Clinicopathologic predictors of survival in buccal squamous cell carcinoma. Journal of Oral Pathology & Medicine. 2020;49(9):857-64.
Wang F, Wen J, Cao S, Yang X, Yang Z, Li H, et al. Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer. BMC Oral Health. 2022;22(1):138.
Subramaniam N, Murthy SP, Vidhyadharan S. 11 Cancers of the Oral Cavity. Comprehensive Management of Head and Neck Cancer. 2021:102.
Huang S, Zhu Y, Cai H, Zhang Y, Hou J. Impact of lymphovascular invasion in oral squamous cell carcinoma: A meta-analysis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2021;131(3):319-28. e1.
Kim MJ, Ahn K-M. Prognostic factors of oral squamous cell carcinoma: the importance of recurrence and pTNM stage. Maxillofacial Plastic and Reconstructive Surgery. 2024;46(1):8.
Spoerl S, Gerken M, Fischer R, Mamilos A, Spoerl S, Wolf S, et al. Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study. Oral Oncology. 2020;111:105009.
Lin N-C, Hsien S-I, Hsu J-T, Chen MY. Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan. Scientific Reports. 2021;11(1):15446.
Choi Y-S, Kim MG, Lee J-H, Park J-Y, Choi S-W. Analysis of prognostic factors through survival rate analysis of oral squamous cell carcinoma patients treated at the National Cancer Center: 20 years of experience. Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2022;48(5):284-91.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Syed Umer Farooq, Syed Muhammad Awais, Sana Ahmad, Waqar Un Nisa, Shazia Naz, Afaq Farooq
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
Share-copy and redistribute the material in any medium or format.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Attribution-You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial-You may not use the material for commercial purposes.
NoDerivatives-If you remix, transform, or build upon the material, you may not distribute the modified material.
No additional restrictions-You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.